Login / Signup

Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.

Alyaa AbdelmaguidLara N RobertsLaura TugoresJennifer R JoslinBeverley Jane HuntKiran ParmarDanilo NebresSalah S NagaEman S KhalilKate Bramham
Published in: Journal of thrombosis and haemostasis : JTH (2022)
Patients with CKD exhibit features of concomitant hypercoagulability measured by ROTEM and platelet dysfunction measured with MEA. eGFR was an independent determinant of platelet dysfunction and hypercoagulability.
Keyphrases
  • small cell lung cancer
  • oxidative stress
  • epidermal growth factor receptor
  • high throughput